Onco Wiki / Maladie

Carcinome à cellules squameuses du canal anal

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDDIS-ANAL-SCC
TypeMaladie
Alias
Canal anal SCCCarcinome analCarcinome à cellules squameuses anales (CSC anal)Cancer de l'anusSCCACarcinome à cellules squameuses de l'anusПлоскоклітинний рак анального каналу
Étatreviewed 2026-05-04 | pending_clinical_signoff
MaladiesAucune déclaration
SourcesAucune déclaration

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_10C21.0
icd_o_3_morphology8070/3
icd_o_3_topography["C21.0", "C21.1", "C21.2"]
oncotree_codeANSC

Capacités

Notes

Anal SCC is HPV-driven (90%) and highly curable in locally advanced stages (~75-85%) with organ-preserving chemoradiation. The Nigro protocol (mitomycin C + 5-FU + RT) is NCCN Category 1 — APR is NOT standard initial treatment. Response assessment at 8-11 weeks post-CRT; confirm residual disease by biopsy before salvage APR. HIV+ patients require same CRT with antiretroviral optimization. Screening: high-resolution anoscopy for HIV+ patients and MSM is recommended.

Utilisé par

Algorithmes

Maladie

Indication

Procédures

Questionnaires

Signal d’alerte

Protocole thérapeutique

Sources